Breaking the Cycle of Bacterial Growth and Resistance
Crestone is a Boulder, Colorado based clinical stage biopharmaceutical company developing new drug candidates with entirely novel mechanisms.
See our progress
Pipeline
Enroll today
Clinical Studies
Get the latest news
Press Releases
Get to know us
Our Team
Who We Are
Boulder, Colorado-based Crestone, Inc. is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism of action small molecule drugs for serious bacterial infections. Our pipeline includes antibacterial agents aiming to treat a variety of serious conditions caused by antibacterial-resistant microbes, from C. difficile infection to MRSA, tuberculosis, and more.
Our Pipeline
Our R&D pipeline includes several programs that address areas of significant and growing unmet medical need, all with novel mechanism of action agents.
Clinical Studies
Clinical Study 19-0021
A Randomized, Double-blind Evaluation of CRS3123 Versus Oral Vancomycin in Adult Patients with Clostridioides difficile Infection. Phase II is enrolling now—find a clinical site near you and contact the study coordinator to see if you may be eligible to participate!
Knowledge Portal
Presentations at the 2022 ASM Microbe
Oral Session: In vivo Pharmacodynamic Evaluation of CRS0540 in the Murine Thigh and Lung Infection Models against Staphylococcus aureus Poster: Potency of the Novel PolC DNA Polymerase...
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a challenging, team-oriented environment with competitive salaries.
Clinical Studies
Learn how you can become part of our ongoing clinical study to fight deadly GI tract infections.